This Groundbreaking FDA-Approved Study Will Use Marijuana Produced by a U.S. Company
CTPharma's collaboration with Yale researchers seems to be the first clinical trial involving U.S.-grown marijuana that is not supplied by the federal government.
CTPharma's collaboration with Yale researchers seems to be the first clinical trial involving U.S.-grown marijuana that is not supplied by the federal government.
The science is unsettled, and a complete evaluation has to consider benefits as well as risks.
The agency takes one small, mostly symbolic step for kind bud.
Obama denied him clemency. Will Trump set him free?
After nearly three years of ghosting research cannabis applicants, the DEA has 30 days to explain its inaction.
Survey data contradict fears that underage cannabis consumption would rise after states allowed recreational use by adults.
A solid majority of congressmen, including 41 Republicans, voted for a spending rider that bars the Justice Department from interfering with the legalization of cannabis for medical or recreational use.
"I think it’s ridiculous I would have to trade one of my rights," said veteran Joshua Raines.
"After all our service members have sacrificed, how can we penalize them for working in their state's legal economy?"
The answer may depend on how you measure patients' legal access to cannabis.
Thomas J. Franzen is going to prison for ordering too much medicine.
Regulators are gearing up for a long debate about the size, shape, and other specifications of edibles.
What a difference a few decades make when it comes to letting the states decide marijuana's status.
The black market is how you get things done when government gets in the way.
Spoiler alert: They didn't find any.
"At a time when the nation's really divided, let's try to do something good," says BudTrader CEO Brad McLaughlin.
Nearly a quarter of the U.S. population lives in a jurisdiction where recreational use is legal.
2018 was a mixed bag, but that means there was still a lot of good news.
Two-thirds of the states have now legalized marijuana for medical or recreational use.
The initiative's success is especially striking given the Mormon church's opposition.
Patients with doctors' recommendations will be allowed to grow their own medicine or buy it from state-licensed dispensaries.
Ballot initiatives in Michigan, Missouri, North Dakota, and Utah will give voters a chance to loosen their cannabis laws.
In one of the country's highest-profile campaigns, featuring Democratic heartthrob Stacey Abrams vs. Trumpian Secretary of State Brian Kemp, Ted Metz is likely pulling enough votes away to force a runoff.
Patrick Beadle was convicted on a drug trafficking charge, even though there's very little evidence he was a dealer.
The FDA approved Epidiolex in June, and today the DEA made it a Schedule V drug, the least restrictive classification for controlled substances.
Two years after the DEA announced it would approve new manufacturers of research cannabis, Sessions refuses to explain why he's sitting on the applications.
Doctors' groups recommend abstinence, but expectant mothers who suffer from severe nausea may reach different conclusions.
The move "highlights the extreme confusion around banking in cannabis."
Two years after accepting applications, the DEA has yet to grant licenses to growers.
The question now: Will the governor and her allies try to override the will of the voters?
Cannabidiol, recognized by most states as a treatment for epilepsy, now has the federal government's blessing.
Arizona jurist Clint Bolick targets judicial pacifism in medical marijuana case.
Although the state recognizes cannabis as a treatment for epilepsy, it says letting your son use it is "reckless conduct."
As medical and recreational marijuana become more widely accepted and legalized, it's not only government agencies that have to deescalate the drug war.
The attorney general claims that approving new producers of cannabis might violate anti-drug treaties.
Epidiolex shows great promise in relieving two severe forms of epilepsy.
He's doing it for the vets. And probably for the potential new customer base.
The interference seems inconsistent with the president's support for cannabis as a medicine.
Next week's budget showdown will include a fight over an amendment prohibiting the DOJ from preventing states from legalizing medical marijuana.
Celebrate your independence with a subscription to Reason magazine, your most trusted source of honest, insightful news and analysis.